miR-181c regulates MCL1 and cell survival in GATA2 deficient cells.

Autor: Wang W; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA., Chen R; Department of Laboratory Medicine, Beijing Tong-Ren Hospital, Capital Medical University, Beijing, China., Droll S; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA., Barber E; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA., Saleh L; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA.; Hematology Section, Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Corrigan-Cummins M; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA., Trick M; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA., Anastas V; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA., Hawk NV; Experimental Transplantation and Immunology Branch, National Cancer Institute (NCI), NIH, Bethesda, Maryland, USA., Zhao Z; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA.; Department of Pathology & Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA., Vinh DC; Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.; Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada., Hsu A; Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Hickstein DD; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA., Holland SM; Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA., Calvo KR; Department of Laboratory Medicine, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, USA.
Jazyk: angličtina
Zdroj: Journal of leukocyte biology [J Leukoc Biol] 2022 Apr; Vol. 111 (4), pp. 805-816. Date of Electronic Publication: 2021 Jul 16.
DOI: 10.1002/JLB.2A1220-824R
Abstrakt: GATA2 is a transcription factor critical for hematopoiesis. Germline mutations in GATA binding protein 2 (GATA2) led to haploinsufficiency, severe cytopenias of multiple cell lineages, susceptibility to infections and strong propensity to develop myelodysplastic syndrome, and acute myeloid leukemia. Mechanisms of progressive cytopenias remain unclear. MicroRNA (miRNA) represents a unique mechanism of post-transcriptional gene regulation. In this study, miRNA profiles were evaluated and eight miRNAs were found to be differentially expressed (≥2-fold, P ≤ 0.05) in patient-derived cell lines (N = 13) in comparison to controls (N = 10). miR-9, miR-181a-2-3p, miR-181c, miR-181c-3p, miR-486-3p, and miR-582 showed increased expression, whereas miR-223 and miR-424-3p showed decreased expression. Cell death assays indicated that miR-181c potently induces cell death in lymphoid (Ly-8 and SP-53) and myeloid (HL-60) cell lines. miR-181c was predicted to target myeloid cell leukemia (MCL)1, which was confirmed by transfection assays, resulting in significantly reduced MCL1 mRNA and decreased live cell numbers. Bone marrow analysis of 34 GATA2 patients showed significantly decreased cellularity, CD34-positive cells, monocytes, dendritic cells, NK cells, B cells, and B cell precursors in comparison to healthy controls (N = 29; P < 0.001 for each), which was accompanied by decreased levels of MCL1 (P < 0.05). GATA2 expression led to significant repression of miR-181c expression in transfection experiments. Conversely, knockdown of GATA2 led to increased miR-181c expression. These findings indicate that miR-181c expression is increased and MCL1 levels decreased in GATA2 deficiency cells, and that GATA2 represses miR-181c transcription. Increased miR-181c may contribute to elevated cell death and cytopenia in GATA2 deficiency potentially through down-regulation of MCL1.
(©2021 Society for Leukocyte Biology. This article has been contributed to by US Government employees and their work is in the public domain in the USA.)
Databáze: MEDLINE
Externí odkaz: